| Display title | Dr A Malik v Cygnet Behavioural Health Ltd (reconsideration) [2021] MHLO 7 (ET) |
| Default sort key | Dr A Malik v Cygnet Behavioural Health Ltd (reconsideration) (2021) MHLO 7 (ET) |
| Page length (in bytes) | 1,258 |
| Page ID | 16031 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Edit | Allow only users with "editing" permission (infinite) |
| Move | Allow only users with "editing" permission (infinite) |
| Page creator | Jonathan (talk | contribs) |
| Date of page creation | 22:08, 2 December 2024 |
| Latest editor | Jonathan (talk | contribs) |
| Date of latest edit | 12:38, 12 December 2024 |
| Total number of edits | 3 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 3 |
| Recent number of distinct authors | 1 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | The claimant sought reconsideration as the original decision contained no specific decision in relation to one of the argued detriments, part 1 of which was her suspension in relation to administration of covert medication, and part 2 of which was the inadequate appeal against dismissal. Part 1 was presented out of time but part 2 was presented in time. The tribunal rejected the respondent's argument that its Article 6 rights would be breached by a finding being made months after the trial, but went on to decide that the appeal was part of the dismissal so was excluded as a detriment and, an any event, was not motivated by the public interest disclosures. |
